| # | Drug | Count |
|---|---|---|
| 0 | INFLIXIMAB | 40 |
| 1 | ADALIMUMAB | 19 |
| 2 | PREDNISONE | 17 |
| 3 | CINACALCET HYDROCHLORIDE | 11 |
| 4 | TACROLIMUS | 10 |
| 5 | UPADACITINIB | 10 |
| 6 | CIPROFLOXACIN | 7 |
| 7 | CIPROFLOXACIN HYDROCHLORIDE | 7 |
| 8 | SILDENAFIL | 7 |
| 9 | SILDENAFIL CITRATE | 7 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | INFLIXIMAB-DYYB | 6 | 0.0017 |
| 1 | ASCORBIC ACID, THIAMINE, RIBOFLAVIN, NIACINAMIDE, PYRIDOXINE, FOLIC ACID, COBALAMIN, BIOTIN, PANTOTHENIC ACID | 1 | 0.0016 |
| 2 | CHLOROTHIAZIDE | 1 | 0.0008 |
| 3 | PAMIDRONATE DISODIUM | 2 | 0.0006 |
| 4 | VAMOROLONE | 1 | 0.0006 |
| 5 | DHEA (DEHYDROEPIANDROSTERONE) | 1 | 0.0005 |
| 6 | MEFENAMIC ACID | 1 | 0.0005 |
| 7 | RILUZOLE | 1 | 0.0004 |
| 8 | DEFLAZACORT | 1 | 0.0004 |
| 9 | CALCIUM ACETATE | 2 | 0.0004 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 43 |
| 1 | Corticosteroid [EPC] | 27 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 15 |
| 3 | Phosphodiesterase 5 Inhibitor [EPC] | 11 |
| 4 | Janus Kinase Inhibitor [EPC] | 10 |
| 5 | Endothelin Receptor Antagonist [EPC] | 9 |
| 6 | Vitamin C [EPC] | 8 |
| 7 | Vitamin D [EPC] | 7 |
| 8 | Benzodiazepine [EPC] | 6 |
| 9 | Nitroimidazole Antimicrobial [EPC] | 6 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Benzothiazole [EPC] | 1 | 0.0004 |
| 1 | Vitamin D2 Analog [EPC] | 2 | 0.0003 |
| 2 | Paramagnetic Contrast Agent [EPC] | 1 | 0.0002 |
| 3 | Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] | 2 | 0.0002 |
| 4 | Potassium Binder [EPC] | 3 | 0.0002 |
| 5 | GLP-2 Analog [EPC] | 2 | 0.0001 |
| 6 | Vitamin D Analog [EPC] | 2 | 0.0001 |
| 7 | Vitamin D3 Analog [EPC] | 2 | 0.0001 |
| 8 | Antimalarial [EPC] | 1 | 0.0001 |
| 9 | Antiprotozoal [EPC] | 1 | 0.0001 |